Poly Medicure Ltd's Q3FY25 Quarter Results
- 04 Feb 2025
Result Summary
- Poly Medicure Ltd reported a -0.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 25.2%.
- Its expenses for the quarter were up by 1.7% QoQ and 24.3% YoY.
- The net profit decreased 2.5% QoQ and increased 31.1% YoY.
- The earnings per share (EPS) of Poly Medicure Ltd stood at 8.5 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 446.01 | 446.11 | 356.17 | -0.0% | 25.2% |
Total Expenses | 334.51 | 328.88 | 269.06 | 1.7% | 24.3% |
Profit Before Tax | 111.51 | 117.98 | 87.82 | -5.5% | 27.0% |
Tax | 28.00 | 30.53 | 22.81 | -8.3% | 22.8% |
Profit After Tax | 85.23 | 87.45 | 65.02 | -2.5% | 31.1% |
Earnings Per Share | 8.50 | 9.00 | 6.80 | -5.6% | 25.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Poly Medicure Ltd is a company primarily engaged in the manufacturing and marketing of medical devices and disposables. It operates within the healthcare industry, offering a wide range of products that include infusion therapy, central venous access catheters, blood management devices, and dialysis products. The company has a significant presence in both domestic and international markets. Recent developments may include expansion in product offerings or strategic partnerships aimed at enhancing its market position and competitive edge. However, specific recent developments are not available in this context.
Revenue
In Q3FY25, Poly Medicure Ltd reported a Total Income of ₹446.01 crores, which marks a stable performance compared to the previous quarter (Q2FY25) where it was ₹446.11 crores, reflecting a negligible QoQ change of -0.0%. On a YoY basis, there is a notable increase of 25.2% from ₹356.17 crores in Q3FY24. This substantial growth indicates a significant year-over-year improvement in revenue generation, highlighting the company's ability to enhance its income streams consistently over the past year.
Profitability
The Profit Before Tax (PBT) for Q3FY25 stood at ₹111.51 crores, which shows a decline of 5.5% from the previous quarter (₹117.98 crores in Q2FY25). However, it is an improvement of 27.0% compared to Q3FY24 when the PBT was ₹87.82 crores. The Tax expense decreased by 8.3% QoQ to ₹28.00 crores, compared to ₹30.53 crores in Q2FY25, but increased by 22.8% YoY from ₹22.81 crores in Q3FY24. Consequently, the Profit After Tax (PAT) for Q3FY25 is ₹85.23 crores, slightly decreasing by 2.5% QoQ from ₹87.45 crores yet rising by 31.1% YoY from ₹65.02 crores. The Earnings Per Share (EPS) for the quarter is ₹8.50, showing a decrease of 5.6% QoQ but a rise of 25.0% YoY.
Operating Metrics
Total Expenses for Q3FY25 amounted to ₹334.51 crores, which represents a 1.7% increase from ₹328.88 crores in Q2FY25 and a 24.3% increase from ₹269.06 crores in Q3FY24. The expense growth aligns with the YoY revenue increase, suggesting consistent operational scaling. The financial data does not directly provide key ratios such as the P/E ratio, debt-to-equity ratio, or current ratio; such calculations would require additional data, including market capitalization, total liabilities, and current assets. Nevertheless, the operating metrics reflect increased cost efficiencies and scale, as evidenced by the higher annual growth in revenue relative to expenses.
